Search Results
Slidesets
Linking “intended use” to evidence needed for bringing a biomarker to market- John Sninsky, PhD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Update on SARS-CoV-2 Virological Diagnostics - Anne-Geneviève Marcelin, MD
Presented at:
COVID-19 Online Educational Program 2020
Slidesets
What is needed to link device approval to clinical application approval?- David Litwack, PhD
Presented at:
International Workshop on NASH Biomarkers 2018
Abstracts
Accelerated HIV case finding & bridging enrolment gap for key populations in Western Nigeria: A breakeven in achieving UNAIDS fast tract 95-95-95 targets
S. Usman
Reviews in Antiviral Therapy & Infectious Diseases 1, 2020
Presented at:
International Workshop on HIV & Women 2020
Abstracts
A multi-country analysis of the impact of COVID-19 on HIV services for pregnant and breastfeeding women and their infants
A. Vrazo
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Viral Hepatitis Cascade of Care Among Adults Living With HIV in Asia-Pacific
D. Rupasinghe
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Slidesets
Establishing the Hepatitis B and C Prevention and Management Program - Malawi’s Experience - Wongani Mzumara.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Reinfection and Protective Immunity After COVID Infection | David W. Eyre, BM, BCh, DPhil
Presented at:
COVID-19 Vaccine Development & Implementation Workshop 2021 - February Edition
Slidesets
Big data vs. the individual liver - regulatory perspective- Robert Schuck, PharmD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017